Jump to Navigation
Quantitative
Research
Quantitative Models
Methodology Graphic
EQR White Paper
Investment
Products
Baker's Dozen Model Portfolio
UITs
ETFs
Investor
Tools
Scorecards
Earnings Busters
Sector Detector
Advisors &
Individual Investors
Go to Investors Site
About Us
Our Company
Our People
ADV2A
Contact Us
Search form
Search
You are here:
You are here
Home
»
Feed aggregator
»
Sources
https://seekingalpha.com
URL:
https://seekingalpha.com
Updated:
40 min 28 sec ago
Elong Power approves 16-for-1 reverse stock split
Tue, 12/23/2025 - 06:50
Cemtrex announces $2 million registered direct offering
Tue, 12/23/2025 - 06:49
Tencent-backed MiniMax unveils 'significantly enhanced' M2.1 model
Tue, 12/23/2025 - 06:44
U.S. strategy is said to target Venezuela’s ghost fleet of oil tankers
Tue, 12/23/2025 - 06:43
Whole Foods takes its new urban grocery store concept to New Jersey
Tue, 12/23/2025 - 06:38
JPMorgan: AI Productivity Gains Make It Worth Premium
Tue, 12/23/2025 - 06:38
Buy The Blue Chip: Ares Capital Is A 9.6% Yielding Bargain
Tue, 12/23/2025 - 06:35
Coterra Energy: Potential For Over $2 Billion In 2026 Free Cash Flow
Tue, 12/23/2025 - 06:33
New Battleships In The Spotlight
Tue, 12/23/2025 - 06:30
Japan's finance minister signals readiness for yen intervention
Tue, 12/23/2025 - 06:30
Global X Silver Miners ETF: Leveraged Exposure To Silver As The Cycle Extends Into 2026
Tue, 12/23/2025 - 06:30
Agree Realty: Buy This Best-Of-Breed REIT On Sale Now
Tue, 12/23/2025 - 06:30
My 6.7% Yield Retirement Blueprint: 5 Stocks I'd Trust With My Future
Tue, 12/23/2025 - 06:30
Aeluma: When A Semiconductor Story Stops Being A Science Project
Tue, 12/23/2025 - 06:20
Costco: The Art Of Execution
Tue, 12/23/2025 - 06:19
Astera Labs: Why 2026 Could Be The Breakout Year
Tue, 12/23/2025 - 05:12
Universal: The Yield Is Attractive But Don't Expect Growth
Tue, 12/23/2025 - 05:02
IUSV: Value Stocks Are Not That Appealing Anymore
Tue, 12/23/2025 - 04:57
Bandai Namco: Growth Isn't The Story--Unit Economics Are
Tue, 12/23/2025 - 04:55
Atea Pharmaceuticals: Potential Best-In-Class HCV Cure With Pivotal Readouts In 2026
Tue, 12/23/2025 - 04:51
Pages
« first
‹ previous
…
1776
1777
1778
1779
1780
1781
1782
1783
1784
…
next ›
last »